← Back to Search

Mobile App Intervention for Risky Alcohol Use (TRAC-ER Trial)

N/A
Waitlist Available
Led By Carolyn Lauckner, PhD
Research Sponsored by Carolyn Lauckner
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 months (assessed up to 2x daily)
Awards & highlights

TRAC-ER Trial Summary

This trial will use mobile apps to deliver messages to reduce risky drinking & HIV risk in sexual minority males & transgender persons. They'll also take surveys & breathalyzer readings to measure outcomes.

Who is the study for?
This trial is for sexual minority males and transgender individuals aged 18-35 who drink alcohol at risky levels, own a smartphone, are HIV-negative, meet CDC PrEP criteria, and identify as non-heterosexual. It's not for those who don't speak English, have severe alcohol withdrawal symptoms or mental illness, or need detox.Check my eligibility
What is being tested?
The study tests the TRAC-ER app intervention that combines GPS tracking with ecological momentary interventions (EMI) to reduce risky alcohol use. When participants visit 'risky' places, they receive messages encouraging strategies from prior sessions and provide data on their drinking behavior.See study design
What are the potential side effects?
Since this intervention involves behavioral strategies rather than medication, traditional side effects are not expected. However, participants may experience stress or discomfort when receiving real-time feedback about their behaviors.

TRAC-ER Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 months (assessed up to 2x daily)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 months (assessed up to 2x daily) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of drinking days
Secondary outcome measures
Number of binge drinking episodes
Drunk driving
Other outcome measures
Alcohol consequences
Alcohol cravings
Ethanol
+17 more

TRAC-ER Trial Design

3Treatment groups
Experimental Treatment
Group I: TRAC-ER plus SAMExperimental Treatment3 Interventions
Participants in this group will receive the Tracking and Reducing Alcohol Consumption (TRAC) intervention combined with GPS-based ecological momentary interventions (EMI) and smartphone-based alcohol monitoring.
Group II: TRAC plus SAMExperimental Treatment2 Interventions
Participants in this group will receive the Tracking and Reducing Alcohol Consumption (TRAC) intervention and smartphone-based alcohol monitoring.
Group III: SAM-Only Comparison GroupExperimental Treatment1 Intervention
Participants in this group will engage only in smartphone-based alcohol monitoring.

Find a Location

Who is running the clinical trial?

National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
799 Previous Clinical Trials
1,362,106 Total Patients Enrolled
Carolyn LaucknerLead Sponsor
2 Previous Clinical Trials
90 Total Patients Enrolled
Carolyn Lauckner, PhDPrincipal InvestigatorUniversity of Kentucky
2 Previous Clinical Trials
90 Total Patients Enrolled

Media Library

TRAC-ER Clinical Trial Eligibility Overview. Trial Name: NCT05576350 — N/A
Human Immunodeficiency Virus Infection Research Study Groups: SAM-Only Comparison Group, TRAC plus SAM, TRAC-ER plus SAM
Human Immunodeficiency Virus Infection Clinical Trial 2023: TRAC-ER Highlights & Side Effects. Trial Name: NCT05576350 — N/A
TRAC-ER 2023 Treatment Timeline for Medical Study. Trial Name: NCT05576350 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this exploration admit people who are of age 20 or older?

"The upper age limit for enrolment in this study is 35 years old, and the lower age limit is 18."

Answered by AI

What criteria make a person eligible for enrollment in this experiment?

"This clinical trial is seeking 405 individuals, aged 18-35 and identifying as a sexual minority male or transgender, to participate. Eligible applicants must own a smartphone, be HIV negative (confirmed through testing), demonstrate at risk alcohol usage behaviours, and meet the CDC guidelines for Prep eligibility."

Answered by AI

Does this research have any open positions for participants?

"Curiously, clinicaltrials.gov does not list this trial as actively recruiting patients anymore. Initially published on March 1st 2023 and last updated in October of 2022, the study is no longer taking partipants; however 851 other medical trials are currently inviting enrollees at this time."

Answered by AI

Who else is applying?

What state do they live in?
Kentucky
What site did they apply to?
University of Kentucky
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
TRAC-ER Intervention to Reduce Risky Alcohol Use Among Sexual Minority Males and Transgender Individuals
Carolyn Lauckner 2024. "TRAC-ER Intervention to Reduce Risky Alcohol Use Among Sexual Minority Males and Transgender Individuals". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05576350.
All > Transgender > Mobile
~270 spots leftby May 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top